These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3791364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis.
    Cucè LC, Assunção BF, Medawar LG, Salibian A, Groppi W.
    J Int Med Res; 1980 Nov; 8(2):144-7. PubMed ID: 6989684
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F, Gartmann H, Weidinger G.
    Z Hautkr; 1984 Sep 15; 59(18):1218-26. PubMed ID: 6388170
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE, Vlahovic TC.
    J Drugs Dermatol; 2014 Jul 15; 13(7):803-8. PubMed ID: 25007362
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
    Kikuchi I, Tanuma H, Morimoto K, Kawana S.
    Mycoses; 2008 Nov 15; 51(6):523-31. PubMed ID: 18422915
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A controlled study of haloprogin and tolnaftate in tinea pedis.
    Carter VH.
    Curr Ther Res Clin Exp; 1972 Jun 15; 14(6):307-10. PubMed ID: 4625803
    [No Abstract] [Full Text] [Related]

  • 18. Topical sertaconazole (ertaczo)--another azole for tinea pedis.
    Med Lett Drugs Ther; 2004 Jun 21; 46(1185):50-1. PubMed ID: 15211288
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.